DIA_CENTRAL:T2D Treatment Pattern in Central Europe

Conditions

• Diabetes Mellitus, Type 2

Interventions

• DRUG: Empagliflozin
• DRUG: Sodium Glucose Transporter 2 inhibitor
• DRUG: Dipeptidyl-peptidase 4 inhibitor
• DRUG: Glucagon-like peptide 1 agonist

Sponsor

Boehringer Ingelheim